ChanTest
-
Drug developer ChanRx closes series A investment, hires CEO
Drug developer ChanRx has closed a series A round of investment that it will use […]
-
“The Cities” awards: ChanTest named Healthcare Ally
Pharmaceutical testing company ChanTest has achieved several “firsts” in its 13 years, most related to […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
ChanRx to use $250K investment to reformulate a-fib drug
Updated 2:47 p.m., Aug. 5, 2010. Two-year-old drug development company ChanRx has received a $250,000 […]
-
Night Read (Ohio): Kendle to open center in India
Kendle International, the clinical research organization in Cincinnati, has received approval from Indian authorities to open an operations center in a Special Economic Zone in the Ahmedabad-Gandhinagar Knowledge Corridor by mid-April.
-
MRIs (and Cleveland) win big in the latest round of Ohio Third Frontier funding
A $10 million public-private deal with Cardinal Health and Ohio State was the largest of several Third Frontier grants for biomedical companies or organizations announced Wednesday. Altogether, imaging companies and organizations received $20 million in funding. Out of eight total grant announcement, Cleveland-area companies were involved in five.
-
ChanTest acquisition of Applied Cell Sciences: ‘the perfect fit’
Dr. Arthur “Buzz” Brown describes his company’s acquisition of a Rockville, Md., contract research organization as a 1-plus-1-equals-5 kind of deal. Last week, ChanTest acquired Applied Cell Sciences in Rockville, Md., for undisclosed terms.